The association between IL-17A and IL-23R polymorphisms and coronary artery disease risk in a Middle Eastern Chinese

Qiang Zhao1,2, Huaxin Jiang3, Teng Ma2

  • 1Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.

Insights

Genetic variations in IL-17A and IL-23R are linked to coronary artery disease (CAD) risk. This study found specific polymorphisms in IL-17A (rs2275913) and IL-23R (rs6682925) associated with increased CAD susceptibility.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Immunology

Background:

  • Interleukin-17A (IL-17A) and Interleukin-23 Receptor (IL-23R) gene polymorphisms may influence gene expression and susceptibility to coronary artery disease (CAD).
  • Previous research on the association between IL-17A/IL-23R polymorphisms and CAD risk has yielded inconclusive results.

Purpose of the Study:

  • To investigate the association between specific polymorphisms in the IL-17A and IL-23R genes and the risk of developing coronary artery disease (CAD).

Main Methods:

  • A hospital-based case-control study involving 191 CAD patients and 131 controls.
  • Genotyping of IL-17A rs2275913 and IL-23R rs6682925 polymorphisms was performed using the Sequenom MassARRAY platform.
  • Patient and control groups were assessed using SXscore, and biochemical parameters like FPG, HbA1C, HDL, ApoA1, and Lp(a) were analyzed.

Main Results:

  • Patients with CAD exhibited higher FPG and HbA1C levels, and lower HDL and ApoA1 levels compared to controls. Lp(a) levels were significantly lower in controls than in cases.
  • The IL-17A rs2275913 (AA vs GG: OR=2.16; AG/AA vs GG: OR=1.81) and IL-23R rs6682925 (CC vs TT: OR=1.91) polymorphisms were associated with an increased risk of CAD.
  • Subgroup analysis indicated that the IL-23R rs6682925 polymorphism was significantly associated with increased CAD risk in patients with a high SXscore (CT/CC vs TT: OR=3.72).

Conclusions:

  • Type 2 Diabetes Mellitus (T2DM), elevated Lp(a), and reduced HDL-c and ApoA1 are identified as risk factors for CAD.
  • The IL-17A rs2275913 and IL-23R rs6682925 polymorphisms may play a role in the susceptibility to developing coronary artery disease.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
934
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
400
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
230
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
351
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
615
Conservation of Small Populations02:04

Conservation of Small Populations

Small population sizes put a species at extreme risk of extinction due to a lack of variation, and a consequent decrease in adaptability. This weakens the chances of survival under pressures such as climate change, competition from other species, or new diseases. Large populations are more likely to survive pressures such as these, as such populations are more likely to harbor individuals that have genetic variants that are adaptive under new stresses. Small populations are much less...
16.7K